review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Marvin S. Medow | Q79244922 |
Rosamund Vallings | Q50505093 | ||
Rosemary A. Underhill | Q70127907 | ||
Kenneth J. Friedman | Q79206274 | ||
Alan Gurwitt | Q79211941 | ||
Nigel Speight | Q79212392 | ||
P2093 | author name string | Julian M Stewart | |
Peter C Rowe | |||
Malcolm S Schwartz | |||
Katherine S Rowe | |||
P2860 | cites work | Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study | Q21089923 |
Hypocapnia is a biological marker for orthostatic intolerance in some patients with chronic fatigue syndrome | Q21093271 | ||
Cognitive behaviour therapy for chronic fatigue syndrome in adults | Q24242121 | ||
Postural neurocognitive and neuronal activated cerebral blood flow deficits in young chronic fatigue syndrome patients with postural tachycardia syndrome | Q24610647 | ||
Myalgic encephalomyelitis: International Consensus Criteria | Q24611510 | ||
Guidelines for the diagnosis and management of syncope (version 2009) | Q24622801 | ||
Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia | Q24649108 | ||
Postural tachycardia syndrome (POTS) | Q26866527 | ||
Immunologic abnormalities in chronic fatigue syndrome | Q28240155 | ||
The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group | Q28241826 | ||
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome | Q28371348 | ||
Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue | Q33144884 | ||
The relationship between health-related quality of life and frequency of spells in patients with syncope | Q33146029 | ||
Catecholamine response during haemodynamically stable upright posture in individuals with and without tilt-table induced vasovagal syncope | Q33148446 | ||
Reflex syncope in children and adolescents | Q33151682 | ||
Tilt testing for syncope: a reappraisal. | Q33152147 | ||
Neurocirculatory abnormalities in chronic orthostatic intolerance | Q33152330 | ||
A matched case control study of orthostatic intolerance in children/adolescents with chronic fatigue syndrome | Q80227660 | ||
Treatment of chronic fatigue and orthostatic intolerance with propranolol | Q80366179 | ||
Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial | Q80797038 | ||
Fibromyalgia and chronic fatigue syndrome in children | Q82670518 | ||
Syncope | Q84450298 | ||
Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study | Q84545761 | ||
Treatment of chronic fatigue syndrome: how to find a 'new equilibrium'? | Q84579681 | ||
Orthostatic tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis | Q84692203 | ||
Impaired range of motion of limbs and spine in chronic fatigue syndrome | Q88080378 | ||
Psychological wellbeing and quality-of-life among siblings of paediatric CFS/ME patients: A mixed-methods study | Q37391354 | ||
Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. | Q37494776 | ||
Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia | Q37700757 | ||
Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO₂peak indicates functional impairment | Q37731889 | ||
Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options | Q37854888 | ||
Interventions in pediatric chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review. | Q38104124 | ||
The Ehlers-Danlos syndrome | Q38180057 | ||
Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial | Q38436937 | ||
The role of hypocortisolism in chronic fatigue syndrome | Q39229578 | ||
Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study | Q39537154 | ||
Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas | Q39654932 | ||
Mindfulness-based cognitive therapy for people with chronic fatigue syndrome still experiencing excessive fatigue after cognitive behaviour therapy: a pilot randomized study | Q39699520 | ||
Adolescent chronic fatigue syndrome: a follow-up study | Q39840558 | ||
Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder. | Q39853295 | ||
Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult. | Q40455926 | ||
Cow's milk protein intolerance in adolescents and young adults with chronic fatigue syndrome | Q40755608 | ||
Hormonal alterations in adolescent chronic fatigue syndrome | Q43144053 | ||
What to do about attention and memory problems in children with CFS/ME: a neuropsychological approach | Q43433983 | ||
Internet-based therapy for adolescents with chronic fatigue syndrome: long-term follow-up | Q43496369 | ||
Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial | Q43517355 | ||
Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls | Q43579573 | ||
Physical and functional impact of chronic fatigue syndrome/myalgic encephalomyelitis in childhood | Q43870008 | ||
Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients | Q43953092 | ||
PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations | Q44207239 | ||
A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome | Q44271088 | ||
Adolescent chronic fatigue syndrome: prevalence, incidence, and morbidity | Q44517402 | ||
Incidence, prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents: a prospective community study | Q45211697 | ||
Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders | Q45264978 | ||
Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome | Q45366547 | ||
Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function | Q45847657 | ||
Disturbed adrenal function in adolescents with chronic fatigue syndrome | Q46424767 | ||
Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome | Q46792317 | ||
Sympathetic cardiovascular control during orthostatic stress and isometric exercise in adolescent chronic fatigue syndrome | Q46860956 | ||
Paediatric chronic fatigue syndrome: complex presentations and protracted time to diagnosis | Q46985836 | ||
Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study | Q48327448 | ||
Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome | Q48384812 | ||
Plasma cytokine expression in adolescent chronic fatigue syndrome | Q48392820 | ||
Single-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome | Q48399848 | ||
Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. | Q48640927 | ||
Effects of rapid saline infusion on orthostatic intolerance and autonomic tone after 20 days bed rest | Q48669238 | ||
Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure | Q48725213 | ||
Musculoskeletal complaints, physical activity and health-related quality of life among patients with the Ehlers-Danlos syndrome hypermobility type | Q48883985 | ||
Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3 T MRI study | Q36326145 | ||
Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia | Q36333690 | ||
Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics | Q36338277 | ||
Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue | Q36346397 | ||
The impact of chronic fatigue syndrome on cognitive functioning in adolescents | Q36494407 | ||
A mitochondrial bioenergetic etiology of disease | Q36734995 | ||
An investigation of symptoms predating CFS onset | Q36794530 | ||
Intravenous immunoglobulin: adverse reactions and management | Q37289504 | ||
Chronic fatigue syndrome after infectious mononucleosis in adolescents | Q37374641 | ||
Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects | Q37376370 | ||
Clinical practice. Neurocardiogenic syncope | Q33152418 | ||
AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research I | Q33153485 | ||
The vasovagal response | Q33153718 | ||
Usefulness of an abnormal cardiovascular response during low-grade head-up tilt-test for discriminating adolescents with chronic fatigue from healthy controls | Q33154967 | ||
Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope | Q33155797 | ||
Fatigue is significant in vasovagal syncope and is associated with autonomic symptoms | Q33156358 | ||
Neurocardiogenic syncope coexisting with postural orthostatic tachycardia syndrome in patients suffering from orthostatic intolerance: a combined form of autonomic dysfunction | Q33159581 | ||
Increasing orthostatic stress impairs neurocognitive functioning in chronic fatigue syndrome with postural tachycardia syndrome | Q33160456 | ||
Common syndromes of orthostatic intolerance | Q33162613 | ||
The Relationship Between Neurally Mediated Hypotension and the Chronic Fatigue Syndrome | Q33173704 | ||
Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope | Q33173817 | ||
Is neurally mediated hypotension an unrecognised cause of chronic fatigue? | Q33173905 | ||
Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents | Q33174058 | ||
Tilt table testing for assessing syncope. American College of Cardiology | Q33174782 | ||
Certain cardiovascular indices predict syncope in the postural tachycardia syndrome | Q33174922 | ||
Neurocardiogenic syncope: response to hormonal therapy | Q33175115 | ||
Neurohormonal response to head-up tilt and its role in vasovagal syncope | Q33175203 | ||
Neurally mediated hypotension and autonomic dysfunction measured by heart rate variability during head-up tilt testing in children with chronic fatigue syndrome | Q33175829 | ||
Orthostatic intolerance in adolescent chronic fatigue syndrome | Q33175931 | ||
Does methylphenidate reduce the symptoms of chronic fatigue syndrome? | Q33232616 | ||
Comparison of 70 degrees tilt, LBNP, and passive standing as measrues of orthostatic tolerance | Q33424038 | ||
Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial | Q33584125 | ||
Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities | Q33594555 | ||
Embolization of the ovarian veins as a treatment for patients with chronic pelvic pain caused by pelvic venous incompetence (pelvic congestion syndrome). | Q33738949 | ||
A community-based study of chronic fatigue syndrome | Q33877546 | ||
Cognitive behaviour therapy for adults with chronic fatigue syndrome | Q33900639 | ||
The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome | Q33911199 | ||
Evidence for a heritable predisposition to Chronic Fatigue Syndrome | Q33914379 | ||
Evidence for the presence of immune dysfunction in chronic fatigue syndrome | Q33943529 | ||
Thirteen-year follow-up of children and adolescents with chronic fatigue syndrome | Q33945042 | ||
Mast cell activation syndrome: Proposed diagnostic criteria. | Q34024510 | ||
DNA methylation modifications associated with chronic fatigue syndrome | Q34027879 | ||
Postural tachycardia in children and adolescents: what is abnormal? | Q34028970 | ||
Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review | Q34043996 | ||
Herbal medicines and perioperative care | Q34083672 | ||
??? | Q28262462 | ||
Cognitive functioning in chronic fatigue syndrome: a meta-analysis | Q34090893 | ||
Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases | Q34102535 | ||
Biochemical and vascular aspects of pediatric chronic fatigue syndrome. | Q34136351 | ||
Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity | Q34243556 | ||
School refusal in children and adolescents | Q34274159 | ||
Diet promotes sleep duration and quality. | Q34278311 | ||
Exercise tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis | Q34287607 | ||
Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012. | Q34306149 | ||
Primary juvenile fibromyalgia syndrome and chronic fatigue syndrome in adolescents | Q34338918 | ||
Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? | Q34359612 | ||
Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial | Q34360232 | ||
Predictors of Post-Infectious Chronic Fatigue Syndrome in Adolescents | Q34411631 | ||
Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents | Q34430548 | ||
Phenylephrine alteration of cerebral blood flow during orthostasis: effect on n-back performance in chronic fatigue syndrome | Q34519033 | ||
“He’s Dizzy When He Stands Up”: An Introduction to Initial Orthostatic Hypotension | Q34532623 | ||
Chronic fatigue syndrome: a working case definition. | Q34553339 | ||
Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial | Q34556618 | ||
Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. | Q34570707 | ||
Factitious disorder by proxy: pediatric condition falsification | Q34594779 | ||
Fatigue is a frequent and clinically relevant problem in Ehlers-Danlos Syndrome | Q34613345 | ||
Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls | Q34615886 | ||
Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. | Q34655467 | ||
Postural tachycardia syndrome (POTS). | Q34941771 | ||
Cognitive-behavior therapy in chronic fatigue syndrome: is improvement related to increased physical activity? | Q34943703 | ||
A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis | Q35204426 | ||
Initial and delayed circulatory responses to orthostatic stress in normal humans and in subjects with orthostatic intolerance | Q35350665 | ||
Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes | Q35466432 | ||
Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia | Q35526128 | ||
Unidentified Chronic Fatigue Syndrome/myalgic encephalomyelitis (CFS/ME) is a major cause of school absence: surveillance outcomes from school-based clinics | Q35629837 | ||
Health related quality of life in adolescents with chronic fatigue syndrome: a cross-sectional study | Q35814560 | ||
Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients | Q36056594 | ||
Less efficient and costly processes of frontal cortex in childhood chronic fatigue syndrome. | Q36109940 | ||
Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). | Q36111648 | ||
Association between school absence and physical function in paediatric chronic fatigue syndrome/myalgic encephalopathy. | Q50769486 | ||
Chronic fatigue syndrome in children aged 11 years old and younger | Q50875950 | ||
Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial | Q50959893 | ||
Comparative study of anxiety, depression, somatization, functional disability, and illness attribution in adolescents with chronic fatigue or migraine | Q51027756 | ||
Memory and attention problems in children with chronic fatigue syndrome or myalgic encephalopathy. | Q51674570 | ||
Japanese clinical guidelines for juvenile orthostatic dysregulation version 1. | Q51834907 | ||
The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome. | Q51889282 | ||
Sympathetic predominance of cardiovascular regulation during mild orthostatic stress in adolescents with chronic fatigue. | Q51912708 | ||
A brief mental fatigue questionnaire. | Q52034007 | ||
Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. | Q54533925 | ||
Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. | Q55068034 | ||
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome | Q55952131 | ||
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols | Q55953405 | ||
The Functional Disability Inventory: Measuring a Neglected Dimension of Child Health Status | Q67898407 | ||
Clinical features of women with chronic lower abdominal pain and pelvic congestion | Q68284184 | ||
Postural tachycardia syndrome. Reversal of sympathetic hyperresponsiveness and clinical improvement during sodium loading | Q70362476 | ||
Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula | Q71737350 | ||
Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome | Q73075310 | ||
The capnography head-up tilt test for evaluation of chronic fatigue syndrome | Q73172609 | ||
Chronic fatigue syndrome symptoms common in patient with vasovagal syncope | Q73548326 | ||
Passive head-up tilt and actively standing up produce similar overall changes in autonomic balance | Q73739644 | ||
Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance | Q74081965 | ||
Joint hypermobility is more common in children with chronic fatigue syndrome than in healthy controls | Q74758222 | ||
A disease epidemic in Iceland simulating poliomyelitis | Q75452672 | ||
Chronic fatigue syndrome in adolescents: a follow-up study | Q76392543 | ||
A twin study of chronic fatigue | Q77221201 | ||
Pelvic congestion syndrome (pelvic venous incompetence): impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic pelvic pain | Q77602253 | ||
P304 | page(s) | 121 | |
P577 | publication date | 2017-06-19 | |
P1433 | published in | Frontiers in pediatrics | Q27725038 |
P1476 | title | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer | |
P478 | volume | 5 |
Q48224891 | Approaching recovery from myalgic encephalomyelitis and chronic fatigue syndrome: Challenges to consider in research and practice. |
Q64268911 | Healthcare Utilization in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Analysis of US Ambulatory Healthcare Data, 2000–2009 |
Q90414688 | Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns |
Q49181667 | Improvement of severe myalgic encephalomyelitis/chronic fatigue syndrome symptoms following surgical treatment of cervical spinal stenosis |
Q92110965 | Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases |
Q64084888 | Meeting the Educational Needs of Young, ME/CFS Patients: Role of the Treating Physician |
Q60046972 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity |
Q92502863 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review |
Q64236158 | Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome |
Q92107037 | Paediatric patients with myalgic encephalomyelitis/chronic fatigue syndrome value understanding and help to move on with their lives |
Q54986633 | Pediatric chronic fatigue syndrome: current perspectives. |
Q98163571 | Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) |
Q59136503 | The Development of the DePaul Symptom Questionnaire: Original, Expanded, Brief, and Pediatric Versions |
Q61812356 | The Importance of Accurate Diagnosis of ME/CFS in Children and Adolescents: A Commentary |
Search more.